Bioceres Crop Solutions Corp. (BIOX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

Revenue TTM

0 200M 400M 600M Q4 '22: 328.5M Q1 '23: 388.9M Q2 '23: 391.2M Q3 '23: 415.9M Q4 '23: 419.4M Q1 '24: 408.8M Q2 '24: 454.5M Q3 '24: 445.6M Q4 '24: 464.8M Q1 '25: 441.3M Q2 '25: 399.9M Q3 '25: 375.4M Q4 '25: 325.5M Q1 '26: 310.3M Q2 '26: 285.1M Q4 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Gross Profit TTM

0 70M 140M 210M Q2 '23: 147.1M Q3 '23: 180.9M Q4 '23: 184.6M Q1 '24: 177.9M Q2 '24: 194.2M Q3 '24: 179.3M Q4 '24: 186.6M Q1 '25: 179.1M Q2 '25: 169.1M Q3 '25: 150.3M Q4 '25: 128.1M Q1 '26: 126.9M Q2 '26: 112M Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Income TTM

0 25M 50M 75M Q4 '22: 39.9M Q1 '23: 46.8M Q2 '23: 31.3M Q3 '23: 59.1M Q4 '23: 54.2M Q1 '24: 42.5M Q2 '24: 57.1M Q3 '24: 40.4M Q4 '24: 45.9M Q1 '25: 42.9M Q2 '25: 40.4M Q3 '25: 28.2M Q1 '23 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25

Net Income TTM

-270M -180M -90M 0 90M 180M 270M Q4 '23: 20.2M Q1 '24: 13.6M Q2 '24: 23.2M Q3 '24: 5.5M Q4 '24: 7.3M Q1 '25: 3.8M Q2 '25: 3.1M Q3 '25: -8.2M Q4 '25: -58.8M Q1 '26: -60.1M Q2 '26: -243.2M Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Cost of Revenue TTM

0 100M 200M 300M Q4 '22: 208.4M Q1 '23: 246.2M Q2 '23: 250M Q3 '23: 240.3M Q4 '23: 235.5M Q1 '24: 231.4M Q2 '24: 261M Q3 '24: 266.2M Q4 '24: 278.2M Q1 '25: 262.4M Q2 '25: 231M Q3 '25: 226.4M Q4 '25: 199.1M Q1 '26: 184.6M Q2 '26: 174.5M Q4 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Cash Flow TTM

0 30M 60M 90M Q4 '23: 2.6M Q1 '24: 49.7M Q2 '24: 29.6M Q3 '24: 10M Q4 '24: 41.7M Q1 '25: 32.1M Q2 '25: 5.7M Q3 '25: 46.4M Q4 '25: 49.9M Q1 '26: 59.1M Q2 '26: 81.9M Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Free Cash Flow TTM

-30M 0 30M 60M 90M Q4 '23: -8.8M Q1 '24: 35.8M Q2 '24: 15.9M Q3 '24: -1.8M Q4 '24: 31.9M Q1 '25: 25.1M Q2 '25: -848.7K Q3 '25: 39.2M Q4 '25: 44.3M Q1 '26: 54.1M Q2 '26: 78.4M Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q2 '20: 36.1M Q2 '21: 39M Q2 '22: 42.4M Q3 '22: 41.1M Q1 '23: 61.7M Q2 '23: 61.7M Q3 '23: 63.1M Q1 '24: 62.8M Q2 '24: 63.9M Q3 '24: 66.8M Q1 '25: 62.9M Q2 '25: 63.2M Q3 '25: 62.8M Q1 '26: 63.4M Q2 '26: 63.5M Q2 '20 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q4 '22: -0.17 Q1 '24: 0.22 Q2 '26: -3.78 Q4 '22 Q1 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.